Plainsboro, NJ, United States of America

Wei-Yong Zhu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Compugen Ltd. Corporation. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-Yong Zhu. Retrieved from https://idiyas.com/inventor/wei-yong-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 338(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wei-Yong Zhu: Innovator in Thrombospondin Research

Introduction

Wei-Yong Zhu is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the study of thrombospondin proteins. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Wei-Yong Zhu holds a patent for a human thrombospondin polypeptide. This patent includes a human thrombospondin 1 protein, polynucleotide encoding the protein, and pharmaceutical compositions thereof. This innovation highlights his expertise in protein research and its potential therapeutic uses.

Career Highlights

Wei-Yong Zhu is currently employed at Compugen Ltd. Corporation, where he continues to advance his research in biotechnology. His work at Compugen has allowed him to explore new frontiers in the understanding of thrombospondin and its applications in medicine.

Collaborations

Some of his notable coworkers include Dvir Dahary and Nili Beck. Their collaborative efforts contribute to the innovative environment at Compugen, fostering advancements in biotechnology.

Conclusion

Wei-Yong Zhu's contributions to thrombospondin research and his patent on related proteins underscore his role as an important inventor in the field. His work continues to pave the way for future innovations in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…